Howe & Rusling’s Pediatrix Medical MD Stock Holding History

Howe & Rusling’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-114	Closed	-$7K	–	931
2017 Q2	$7K	Hold	114	–	–	﹤0.01%	550
2017 Q1	$8K	Hold	114	–	–	﹤0.01%	563
2016 Q4	$8K	Hold	114	–	–	﹤0.01%	561
2016 Q3	$8K	Hold	114	–	–	﹤0.01%	566
2016 Q2	$8K	Hold	114	–	–	﹤0.01%	529
2016 Q1	$7K	Sell	114 -25	-18%	-$1.66K	﹤0.01%	601
2015 Q4	$10K	Hold	139	–	–	﹤0.01%	502
2015 Q3	$11K	Hold	139	–	–	﹤0.01%	483
2015 Q2	$10K	Sell	139 -2,400	-95%	-$173K	﹤0.01%	521
2015 Q1	$184K	Sell	2,539 -24	-0.9%	-$1.67K	0.04%	158
2014 Q4	$169K	Hold	2,563	–	–	0.04%	157
2014 Q3	$141K	Hold	2,563	–	–	0.03%	170
2014 Q2	$149K	Sell	2,563 -7	-0.3%	-$412	0.03%	173
2014 Q1	$159K	Hold	2,570	–	–	0.04%	162
2013 Q4	$137K	Hold	2,570	–	–	0.03%	170
2013 Q3	$128K	Hold	2,570	–	–	0.05%	173
2013 Q2	$118K	Buy	+2,570	New	+$115K	0.03%	202

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Howe & Rusling's MD Position: Q3 2017 in Review

Howe & Rusling sold out of Pediatrix Medical (MD) in Q3 2017, closing a stake of 114 shares — an estimated $7K sold.

Howe & Rusling first reported a position in MD in Q2 2013 and held it in 17 quarters. The position peaked at $184K in Q1 2015. 337 funds tracked by Wall St. Rank hold MD as of Q3 2017.

Howe & Rusling reported no remaining Pediatrix Medical position as of Q3 2017 after selling out during the quarter.
Howe & Rusling sold 114 Pediatrix Medical shares in Q3 2017, an estimated $7K.
Howe & Rusling first reported a position in Pediatrix Medical in Q2 2013 and held it in 17 quarters.
Howe & Rusling's Pediatrix Medical position peaked at $184K in Q1 2015.
337 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2017.

Based on Howe & Rusling's 13F filing for Q3 2017, filed 18 Oct 2017.